Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neil Herskowitz Insider Profile
11 Followers
Neil Herskowitz, Director at TG Therapeutics, holds 134.81K shares in Checkpoint Therapeutics (Ticker: CKPT), holds 97.00 shares in Avenue Therapeutics (Ticker: ATXI), holds 81.44K shares in Journey Medical Corp (Ticker: DERM).
Profitable Transactions
10 out of 13 Profitable Transactions
Average Return
+30.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neil Herskowitz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 15, 2019 - Apr 15, 2020
Return:+101.00%
The most profitable trade made by Neil Herskowitz
Neil Herskowitz's Trading History
TG Therapeutics
Jun 10, 2014
Director
Uninformative Buy
―
$2.58M
Origo Acquisition Corporation
May 23, 2016
―
Uninformative Sell
―
$190.00K
National Holdings
―
―
―
$196.93K
Avenue Therapeutics
Dec 03, 2024
Director
Informative Sell
46.00
$171.69
Checkpoint Therapeutics
Dec 17, 2024
Director
Uninformative Buy
―
$505.55K
Mustang Bio
Jul 07, 2023
Director
Uninformative Buy
―
$3.29K
Journey Medical Corp
Jul 10, 2024
Director
Uninformative Buy
―
$381.16K
List of latest transactions for each holding click on a transaction to see Neil Herskowitz's performance on stock
You May Also Like
Neil Herskowitz insider profile FAQ
What is the percentage of profitable transactions made by Neil Herskowitz?
The percentage of profitable transactions made by Neil Herskowitz is 77%.
What is the average return per transaction made by Neil Herskowitz?
The average return per transaction made by Neil Herskowitz is 30.90%.
What stocks does Neil Herskowitz hold?
Neil Herskowitz holds: TGTX, OACQF, NHLD, ATXI, CKPT, MBIO, DERM stocks.
What was Neil Herskowitz’s latest transaction?
Neil Herskowitz latest transaction was an Uninformative Buy of ―.
What was Neil Herskowitz's most profitable transaction?
Neil Herskowitz’s most profitable transaction was an Informative Buy of ATXI stock on April 15, 2019. The return on the trade was 101.00%.
What is Neil Herskowitz's role in TG Therapeutics?
Neil Herskowitz's role in TG Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.